NCT00473616View on ClinicalTrials.gov

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

PHASE1TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Advanced Solid TumorsCancerAdvanced Solid Malignancies
Interventions
DRUG

AZD7762

intravenous infusion

DRUG

Irinotecan

intravenous injection

Trial Locations (3)

Unknown

Research Site, Boston

Research Site, New York

Research site, Nashville

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY